# The Company That Wants to Make the Endocannabinoid System as Measurable as Blood Sugar > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/the-company-that-wants-to-make-the-endocannabinoid-system-as-measurable-as-blood-sugar/ > **Published:** 2026-09-07T12:12:45-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:45:25-04:00 > **Clinical Summary:** Learn about ECS Restore's efforts to make endocannabinoid system measurements as routine as blood sugar tests, potentially revolutionizing cannabis therapy. --- ✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchNeurologyMental HealthIndustryDosingSafety Why This Matters This article matters for clinicians and their patients because it highlights the potential development of a method to measure the endocannabinoid system (ECS) levels, similar to blood sugar. Such a tool could enable personalized cannabis therapy, improving patient outcomes by ensuring appropriate dosage and treatment selection based on individual ECS profiles. This advancement in understanding and measuring the ECS could significantly impact clinical practice in managing various conditions where cannabis is used as a therapeutic option. Clinical Summary This article discusses the development of ECS Restore, a company aiming to create a method for measuring the endocannabinoid system (ECS) levels, similar to blood sugar measurements. If successful, this could potentially lead to personalized cannabis-based treatments based on individual ECS imbalances, improving patient care and precision in cannabis medicine practice. The practical takeaway is that clinicians may soon have a tool to better understand and treat their patients’ endocannabinoid systems, enhancing the effectiveness of cannabis-based therapies. Dr. Caplan’s Take “As a seasoned family physician specializing in cannabis medicine, the potential for quantifying the endocannabinoid system holds immense promise for personalized healthcare. However, while this innovative approach by ECS Restore is intriguing, it’s crucial to await robust human trials and peer-reviewed evidence before integrating such technology into clinical practice.” Clinical Perspective 🔬 Intriguing development: A company aims to quantify the endocannabinoid system (ECS) akin to blood sugar levels, potentially revolutionizing our understanding and treatment of cannabis-related therapies. While this advancement could offer personalized medicine opportunities, it’s crucial to acknowledge the complexity of ECS regulation and its myriad roles in various physiological processes. Confounders such as genetics, lifestyle factors, and interactions with exogenous cannabinoids may influence ECS measurements, necessitating careful interpretation. In clinical practice, this innovation could pave the way for more precise dosing and monitoring of cannabis-based treatments, ultimately improving patient outcomes and safety. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20The%20Company%20That%20Wants%20to%20Make%20the%20Endocannabinoid%20System%20as%20Measurable%20as%20Blood%20Sugar%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90857)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90857)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20The%20Company%20That%20Wants%20to%20Make%20the%20Endocannabinoid%20System%20as%20Measurable%20as%20Blood%20Sugar%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90857)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [5 Stunning Ways Emergent Systems in Biology Shape Your Life](https://cedclinic.com/emergent-systems-in-biology/) - [When Confidence Replaces Competence: A Rebuttal to WSJ’s Cannabis Coverage](https://cedclinic.com/cherry-picking-cannabis-science-risks-realities/) - [Cannabis and Sexuality: 4 Key Benefits for Intimacy](https://cedclinic.com/cannabis-and-sexuality-benefits-intimacy/) 📰 Source: [https://businessofcannabis.com/the-company-that-wants-to-make-the-endocannabinoid-system-as-measurable-as-blood-sugar/](https://businessofcannabis.com/the-company-that-wants-to-make-the-endocannabinoid-system-as-measurable-as-blood-sugar/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).